HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The impact of whole human blood on the kinetic inertness of platinum(iv) prodrugs - an HPLC-ICP-MS study.

Abstract
The potential advantage of platinum(iv) complexes as alternatives to classical platinum(ii)-based drugs relies on their kinetic stability in the body before reaching the tumor site and on their activation by reduction inside cancer cells. In this study, an analytical workflow has been developed to investigate the reductive biotransformation and kinetic inertness of platinum(iv) prodrugs comprising different ligand coordination spheres (respectively, lipophilicity and redox behavior) in whole human blood. The distribution of platinum(iv) complexes in blood pellets and plasma was determined by inductively coupled plasma-mass spectrometry (ICP-MS) after microwave digestion. An analytical approach based on reversed-phase (RP)-ICP-MS was used to monitor the parent compound and the formation of metabolites using two different extraction procedures. The ligand coordination sphere of the platinum(iv) complexes had a significant impact on their accumulation in red blood cells and on their degree of kinetic inertness in whole human blood. The most lipophilic platinum(iv) compound featuring equatorial chlorido ligands showed a pronounced penetration into blood cells and a rapid reductive biotransformation. In contrast, the more hydrophilic platinum(iv) complexes with a carboplatin- and oxaliplatin-core exerted kinetic inertness on a pharmacologically relevant time scale with notable amounts of the compound accumulated in the plasma fraction.
AuthorsSarah Theiner, Márkó Grabarics, Luis Galvez, Hristo P Varbanov, Nadine S Sommerfeld, Mathea S Galanski, Bernhard K Keppler, Gunda Koellensperger
JournalDalton transactions (Cambridge, England : 2003) (Dalton Trans) Vol. 47 Issue 15 Pg. 5252-5258 (Apr 17 2018) ISSN: 1477-9234 [Electronic] England
PMID29560976 (Publication Type: Journal Article)
Chemical References
  • Coordination Complexes
  • Ligands
  • Organoplatinum Compounds
  • Prodrugs
  • Oxaliplatin
  • Carboplatin
Topics
  • Carboplatin (blood, pharmacokinetics)
  • Chromatography, High Pressure Liquid
  • Coordination Complexes (blood, pharmacokinetics)
  • Humans
  • Hydrophobic and Hydrophilic Interactions
  • Kinetics
  • Ligands
  • Nanospheres (chemistry)
  • Organoplatinum Compounds (blood, pharmacokinetics)
  • Oxaliplatin
  • Oxidation-Reduction
  • Prodrugs (pharmacokinetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: